Carbosayoka 450mg Injection
Marketer
Sayoka Pharmaceutical (OPC) Pvt Ltd
Salt Composition
Carboplatin (450mg)
Overview Carbosayoka 450mg Injection
Oncaspar 450mg Injection treats ovarian and small cell lung cancers by inhibiting or reducing cancerous cell proliferation. Administered intravenously under medical supervision, dosage and frequency are determined by your physician based on your condition and may vary. Strictly adhere to your doctor's prescribed regimen; incorrect usage or overdose can lead to severe adverse effects. Therapeutic benefits may take weeks or months to manifest; discontinue only upon your doctor's instruction. Common side effects include nausea, vomiting, tiredness, and elevated liver enzymes. This medication can lower blood cell counts (red and white), increasing infection and bleeding risks. Report fever, sore throat, chills, unusual bleeding/bruising, or dark urine to your doctor immediately. Regular blood tests monitoring blood cell counts, heart function, liver health, and uric acid levels are necessary. Report any allergic reactions like skin rash, itching, or breathing difficulties. Inform your healthcare provider of all other medications you're taking, as interactions are possible. This injection is contraindicated during pregnancy and breastfeeding; reliable contraception is crucial for both partners throughout treatment.
Primary Ingredients of Carbosayoka 450mg Injection
There is no text provided to rephrase.
Uses of Carbosayoka 450mg Injection
Cancers of the ovary and lung (small cell type)
Major Benefits of Carbosayoka 450mg Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
Common Side effects of Carbosayoka 450mg Injection:
- Nausea
- Vomiting
- Anemia (low number of red blood cells)
- Fatigue
- Low blood platelets
- Increased liver enzymes
- Decreased white blood cell count (neutrophils)
- Stomatitis (Inflammation of the mouth)
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Diarrhea
How to use Carbosayoka 450mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Carbosayoka 450mg Injection works:
OncoSayoka 450mg Injection is a cancer treatment. Its mechanism involves disrupting the genetic makeup (DNA and RNA) of cancerous cells, thereby halting their proliferation.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The safety of alcohol consumption alongside Carbosayoka 450mg Injection is undetermined. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Carbosayoka 450mg Injection during pregnancy poses a confirmed risk to the fetus. Its use should be strictly avoided except in exceptional, life-threatening circumstances where the potential benefits clearly outweigh the known hazards, as determined by a physician. Always seek medical advice.
Breast feedingUNSAFE
Administering Carbosayoka 450mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Administering Carbosayoka 450mg Injection might reduce attentiveness, impair visual acuity, and induce drowsiness or dizziness. Refrain from operating a vehicle should these effects manifest.
KidneyCAUTION
Patients with impaired kidney function should use Carbosayoka 450mg Injection cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Renal function should be regularly monitored during treatment; consult a physician for guidance.
LiverSAFE IF PRESCRIBED
Carbosayoka 450mg Injection is likely safe for individuals with hepatic impairment. Available evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
What if you forget to take Carbosayoka 450mg Injection :
Should you forget a Carbosayoka 450mg Injection, seek medical advice.
Facts to Know About Carbosayoka 450mg Injection
| Label | Value |
|---|---|
| Chemical Type | Platinum Equivalents |
| Developing Habits | No. |
| Treatment Category | Cancer Therapeutics |
| Behavioral Class | Platinum-based Anticancer Agents |
3,018 People bought this recently